Furthermore, LOX-1 is associated with pancreatic cancer drug resistance, the long-chain non-coding RNA GSTM3TV2 can up-regulate LOX-1 and promote the resistance of pancreatic cancer cells to gemcitabine (120). This evidence concerns the gene OLR1 and familial pancreatic carcinoma.